Tianjin Chase Sun Pharmaceutical Co., Ltd. provided earnings guidance for the nine months ended September 2013. The company predicted net profit attributable to shareholders of CNY 237.5306 million to CNY 255.1255 million in January-September period, rising 35% to 45% year on year.